The present invention relates to novel compounds useful as malic enzyme (ME) inhibitors, processes for their preparation and use of these compounds for the therapeutic treatment of disorders mediated by ME such as cancers (e.g. pancreatic ductal adenocarcinoma (PDAC)) in humans.
本发明涉及一种新型化合物,可用作苹果酸酶(ME)
抑制剂,以及用于制备这些化合物的方法和利用这些化合物治疗由ME介导的疾病,如人类的癌症(例如胰腺导管腺癌(
PDAC))。